BioSpace News Archive

Business

Littlebird Connected Care Announces Ex-MIRROR Executive Kristie D’Ambrosio-Correll Joining as Chief Technology Officer and Co-founder

Little receives patent for its Bluetooth Chain of Custody technology as D’Ambrosio-Correll joins following in-home fitness company MIRROR’s successful $500M acquisition by lululemon.

January 17, 2023
·
3 min read
Business

Carver Biosciences Announces Appointment of Three Members to its Scientific Advisory Board

Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the formation of its Scientific Advisory Board (SAB).

January 17, 2023
·
3 min read
Business

TandemAI Announces Appointment of Alessandro Monge, Ph.D., as Chief Business Officer

TandemAI, a technology company focused on transforming drug discovery infrastructure, today announced the appointment of Alessandro Monge, PhD, as Chief Business Officer.

January 17, 2023
·
2 min read
Pharm Country

Actinium Pharmaceuticals, Inc. to Present at the 3rd Annual B. Riley Securities Oncology Conference

Actinium Pharmaceuticals, Inc. today announced that the Company’s management team will participate in a fireside chat on Thursday, January 19, 2023 at 10:30 AM EST at the 3rd Annual B. Riley Securities Oncology Conference.

January 17, 2023
·
4 min read
Aeterna Zentaris Provides Business Update and Outlines Key Upcoming Milestones

Aeterna Zentaris Inc., a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, provided a business update and outlined upcoming key milestones.

January 17, 2023
·
10 min read
Drug Development

Biomea Fusion Doses First Patient in Phase I/Ib Clinical Trial (COVALENT-102) of BMF-219 in KRAS Mutant Solid Tumors

Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA) today announced that the first patient has been dosed in COVALENT-102, the company’s Phase I/Ib trial of BMF-219, an oral, selective, covalent menin inhibitor in patients with KRAS-mutated unresectable, locally advanced, or metastatic NSCLC, CRC, and PDAC.

January 17, 2023
·
7 min read
Business

LuSeed Vascular Appoints Robert Stern to its Board of Directors

LuSeed Vascular, the developer of an innovative solution for the treatment of brain aneurysms, has announced that Robert Stern, an experienced medical device executive and investor, has been nominated as Vice Chairman of the Board of Directors.

January 17, 2023
·
2 min read
Business

AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China

AffaMed Therapeutics (“AffaMed”) today announced that it has entered into an agreement with Eli Lilly and Company (“Eli Lilly”) to obtain sole commercialization rights to import, market, promote, distribute and detail Galcanezumab once approved in Mainland China.

January 17, 2023
·
4 min read
MedRhythms Announces Positive Topline Results from Pivotal Trial in Chronic Stroke

MedRhythms announced today that the company’s pivotal trial for MR-001, a novel digital intervention in development to treat gait deficits in chronic stroke, was successfully completed and met its primary endpoint.

January 17, 2023
·
3 min read
Drug Development

BioCentriq Announces Successful Tech Transfer From Avenge Bio for Manufacturing of Drug Product AVB-001 Resulting in Dosing of First Patient in Phase 1/2 Clinical Trial

BioCentriq, Inc. announced today that they have successfully completed tech transfer of AVB-001 from client Avenge Bio and initiated manufacturing of clinical grade material, which will support Avenge Bio’s ongoing phase 1/2 clinical trial.

January 17, 2023
·
3 min read